The specific inhibitors of PTP1B in this article are not only considered as potential pre-drugs for treating diabetes and obesity but also as probers to discover the effect of PTP1B in the insulin signaling pathway. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.